AP3199A - Agomelatine hydrobromide hadrate and preparation thereof - Google Patents

Agomelatine hydrobromide hadrate and preparation thereof

Info

Publication number
AP3199A
AP3199A AP2012006493A AP2012006493A AP3199A AP 3199 A AP3199 A AP 3199A AP 2012006493 A AP2012006493 A AP 2012006493A AP 2012006493 A AP2012006493 A AP 2012006493A AP 3199 A AP3199 A AP 3199A
Authority
AP
ARIPO
Prior art keywords
hadrate
preparation
agomelatine hydrobromide
agomelatine
hydrobromide
Prior art date
Application number
AP2012006493A
Other languages
English (en)
Other versions
AP2012006493A0 (en
Inventor
Peng Zhang
Xueyan Zhu
Xiong Yu
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44599557&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3199(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2012006493A0 publication Critical patent/AP2012006493A0/xx
Application granted granted Critical
Publication of AP3199A publication Critical patent/AP3199A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2012006493A 2010-03-17 2011-03-17 Agomelatine hydrobromide hadrate and preparation thereof AP3199A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2010101262639A CN102190595A (zh) 2010-03-17 2010-03-17 阿戈美拉汀溴化氢水合物及其制备方法
PCT/CN2011/071912 WO2011113363A1 (en) 2010-03-17 2011-03-17 Agomelatine hydrobromide hydrate and preparation thereof

Publications (2)

Publication Number Publication Date
AP2012006493A0 AP2012006493A0 (en) 2012-10-31
AP3199A true AP3199A (en) 2015-03-31

Family

ID=44599557

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006493A AP3199A (en) 2010-03-17 2011-03-17 Agomelatine hydrobromide hadrate and preparation thereof

Country Status (39)

Country Link
US (1) US8729132B2 (xx)
EP (1) EP2547650B1 (xx)
JP (1) JP5634533B2 (xx)
KR (1) KR101406736B1 (xx)
CN (2) CN102190595A (xx)
AP (1) AP3199A (xx)
AU (1) AU2011229619B2 (xx)
BR (1) BR112012023173B1 (xx)
CA (1) CA2792430C (xx)
CL (1) CL2012002541A1 (xx)
CR (1) CR20120461A (xx)
CU (1) CU20120136A7 (xx)
CY (1) CY1117134T1 (xx)
DK (1) DK2547650T3 (xx)
EA (1) EA022066B1 (xx)
EC (1) ECSP12012156A (xx)
ES (1) ES2572427T3 (xx)
GE (1) GEP20156232B (xx)
GT (1) GT201200260A (xx)
HK (1) HK1177732A1 (xx)
HN (1) HN2012001923A (xx)
HR (1) HRP20151343T1 (xx)
HU (1) HUE026673T2 (xx)
IL (1) IL221783A (xx)
MA (1) MA34054B1 (xx)
ME (1) ME02309B (xx)
MX (1) MX2012010594A (xx)
MY (1) MY160337A (xx)
NI (1) NI201200141A (xx)
NZ (1) NZ602451A (xx)
PE (1) PE20130014A1 (xx)
PL (1) PL2547650T3 (xx)
PT (1) PT2547650E (xx)
RS (1) RS54449B1 (xx)
SG (1) SG183869A1 (xx)
SI (1) SI2547650T1 (xx)
TN (1) TN2012000436A1 (xx)
UA (1) UA105424C2 (xx)
WO (1) WO2011113363A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2978916B1 (fr) 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
CN102718675B (zh) * 2012-06-07 2015-03-25 上海右手医药科技开发有限公司 阿戈美拉汀甲磺酸复合物及其制备方法
KR20150020191A (ko) * 2012-05-14 2015-02-25 상하이 라이트핸드 팜테크 주식회사 아고멜라틴 산기 복합체와 그의 제조방법 및 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CZ20031397A3 (cs) * 2000-10-30 2003-11-12 Teva Pharmaceutical Industries Ltd. Nové krystalické a solvatované formy ondansetron hydrochloridu a způsoby jejich přípravy
FR2890562B1 (fr) * 2005-09-09 2012-10-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime
FR2899472B1 (fr) * 2006-04-07 2008-09-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
CN101585779B (zh) * 2009-03-10 2014-04-02 上海医药工业研究院 阿戈美拉汀的晶型vi及其制备方法和应用

Also Published As

Publication number Publication date
IL221783A (en) 2017-11-30
CN102892749B (zh) 2014-11-05
ES2572427T3 (es) 2016-05-31
PT2547650E (pt) 2015-11-30
HN2012001923A (es) 2015-09-14
EP2547650A1 (en) 2013-01-23
GEP20156232B (en) 2015-01-26
CN102190595A (zh) 2011-09-21
JP5634533B2 (ja) 2014-12-03
KR20120128713A (ko) 2012-11-27
ECSP12012156A (es) 2012-12-28
HK1177732A1 (en) 2013-08-30
MA34054B1 (fr) 2013-03-05
PE20130014A1 (es) 2013-01-26
EP2547650B1 (en) 2015-11-04
CL2012002541A1 (es) 2013-01-11
SI2547650T1 (sl) 2016-02-29
US8729132B2 (en) 2014-05-20
WO2011113363A1 (en) 2011-09-22
CU20120136A7 (es) 2012-12-17
JP2013522242A (ja) 2013-06-13
CN102892749A (zh) 2013-01-23
MY160337A (en) 2017-02-28
AU2011229619A1 (en) 2012-09-27
MX2012010594A (es) 2012-10-03
US20130012592A1 (en) 2013-01-10
CA2792430A1 (en) 2011-09-22
PL2547650T3 (pl) 2016-06-30
NZ602451A (en) 2014-10-31
DK2547650T3 (en) 2016-02-15
TN2012000436A1 (en) 2014-01-30
EA201201293A1 (ru) 2013-04-30
CA2792430C (en) 2015-12-08
CR20120461A (es) 2012-11-29
RS54449B1 (en) 2016-06-30
GT201200260A (es) 2013-11-18
BR112012023173B1 (pt) 2021-08-24
SG183869A1 (en) 2012-10-30
AU2011229619B2 (en) 2014-05-22
KR101406736B1 (ko) 2014-06-12
EP2547650A4 (en) 2013-09-18
BR112012023173A2 (pt) 2016-05-17
CY1117134T1 (el) 2017-04-05
HRP20151343T1 (hr) 2016-01-01
ME02309B (me) 2016-06-20
HUE026673T2 (en) 2016-07-28
EA022066B1 (ru) 2015-10-30
NI201200141A (es) 2012-11-09
UA105424C2 (uk) 2014-05-12
AP2012006493A0 (en) 2012-10-31

Similar Documents

Publication Publication Date Title
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
HK1187049A1 (en) Bisaryl-bonded aryltriazolones and use thereof
EP2657188A4 (en) FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME
HRP20150071T1 (xx) Agomelatin hidroklorid hidrat i njegova priprava
PL2605757T3 (pl) Preparaty oparte na nalbufinie i ich zastosowania
EP2608785A4 (en) LIPOMA CYCLES AND ITS USES
ZA201302854B (en) Substituted benzamides and their uses
PL2521445T3 (pl) Preparat i jego zastosowanie
IL223180A0 (en) Agomelatine intermediates and preparation method thereof
EP2529013A4 (en) NOVEL BETA GLUCOSIDASE AND USES THEREOF
AP3199A (en) Agomelatine hydrobromide hadrate and preparation thereof